AP: Prescription painkiller sales have 'exploded,' leading experts to fear 'addiction epidemic'

Apr 6 2012NewsGuard 100/100 Score

The Associated Press: Painkiller Sales Soar Around US, Fuel Addiction
Sales of the nation's two most popular prescription painkillers have exploded in new parts of the country, an Associated Press analysis shows, worrying experts who say the push to relieve patients' suffering is spawning an addiction epidemic. From New York's Staten Island to Santa Fe, N.M., Drug Enforcement Administration figures show dramatic rises between 2000 and 2010 in the distribution of oxycodone, the key ingredient in OxyContin, Percocet and Percodan. Some places saw sales increase sixteenfold (Hawley, 4/5).

http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Posted in: Medical Condition News | Healthcare News | Pharmaceutical News

Tags: , , , , , ,

Comments (0)

Suggested Reading

Psychedelics: A new hope for substance abuse treatment
Diabetes drugs may reduce risk of opioid overdose and alcohol intoxication
Best ways to quit smoking: E-cigs, medications, and counseling proven effective in new Cochrane analysis
Global mental illness risks linked to commercial factors
GLP-1 receptor agonists show promise in treating substance use disorders
UK to ban disposable vapes in effort to protect youth health and environment
Playing video games for a couple of hours a day can improve mental health
GPePV neurons identified as key players in controlling cocaine addiction behaviors

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Flavored e-cigarettes cut smoking rates and toxic exposure in high-risk groups